News
A New MRI Device Offers Improved Breast Cancer Diagnosis
With VIDA, Sheba offers earlier and more accurate detection of breast cancer
Read More
West Bank and Gaza Medical Professionals Attend a Milestone Sheba Oncology Conference
Highlighting the latest in cancer care, with a particular focus on pediatrics, the Recent Advances in Cancer Care (REACT) 2023 event was attended by over 100 doctors, healthcare executives, medical students, and Palestinian officials from the West Bank and Gaza strip. As part of the REACT 2023 regional conference, which took place on Monday, March […]
Read More
Isenia’s Battle with Alveolar Sarcoma
At 17, Isenia, a native of Semey, Kazakhstan, noticed a lump on her leg the size of a small apple. Initially, Isenia and her family thought it to be a dancing-related injury. However, as months passed, the lump showed no signs of change, so Isenia decided to seek medical attention and was soon diagnosed with […]
Read More
Sheba Study Indicates Readily-Available Drugs May Prevent Metastasis in Colon and Rectal Cancer Patients
Favorable responses to the treatment were noted by Prof. Shamgar Ben-Eliyahu, a neuroscientist specializing in psychoneuroimmunology (PNI) at TAU’s Sagol School of Neuroscience and School of Psychological Sciences, and Prof. Oded Zamora of TAU’s Sackler Faculty of Medicine, who led the study. “Our treatment reduced markers of metastasis in the tumor tissue and decreased the […]
Read More
Antibody Levels Remain High Two Months After Receiving the Second Dose of the COVID-19 Vaccine
According to the latest data, the Pfizer-BioNTech COVID-19 vaccine remains effective for at least two months after receiving the second jab. Click here to learn more.
Read More
A New Drug Discovery and Personalized Treatment Approach for Ulcerative Colitis
Ulcerative colitis is a chronic disease of the large intestine in which the colon’s lining becomes inflamed and develops tiny open sores or ulcers that require lifelong treatment. Patients respond differently or fail to respond to therapies, resulting in their exposure to unnecessary drugs and a delay in the provision of effective treatment. CollPlant, a […]
Read More
Onsite CAR T-Cell Therapy Holds Significant Advantages for Cancer Patients, Despite Challenges
CAR T-cell therapy is an advanced treatment for blood cancers, in which T-cells, also known as T-lymphocytes, which are a type of white blood cell involved in the body’s immune response, are re-engineered to attack malignant cells. This is accomplished by modifying the CAR receptors on T-cell membranes so that they bind to antigens on […]
Read More
New Sheba Study Suggests: Teen Obesity Increases Risk of Type 1 Diabetes
Sheba researchers collected health data on nearly 1.5 million 17-year-olds (58% male, 42% female) who were given medical evaluations before they began Israeli military service in 1996, and then followed their health histories through 2016. At the beginning of the study, none of the subjects showed any abnormalities in blood sugar levels, but over the […]
Read More